Concepedia

Matthew H. G. Katz

MH

Statistics

Publications

294

Citations

24.6K

H-Index

74

Active since

1984

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

University of California San Diego

Mayo Clinic

Moffitt Cancer Center

Matthew H. G. Katz is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and pancreatic cancer.

ORCID

Publications per year

1984–2024

294

Publications

294

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

Leore T. Geller, Michal Barzily-Rokni, Tal Danino et al. · Science · 2017 · 1.8K citations · Full text

, , +16

Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes

Erick Riquelme, Yu Zhang, Liangliang Zhang et al. · Cell · 2019 · 1.6K citations · Full text

, , +14

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans et al. · Journal of the American College of Surgeons · 2008 · 820 citations · Full text

, , +13

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Shuji Isaji, Shugo Mizuno, John A. Windsor et al. · Pancreatology · 2017 · 783 citations · Full text

, , +17

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale et al. · Cancer · 2012 · 527 citations · Full text

, , +17

1–5 of 294